ℹ️
🇬🇧
Search
Search for publications relevant for "overall survival and progression-free survival"
overall survival and progression-free survival
Publication
Class
Person
Publication
Programmes
publication
The authors' own experience with axitinib in treating metastatic renal cell carcinoma
2018 |
First Faculty of Medicine
publication
Chronic myeloid leukemia. Recommendations for diagnosis, monitoring and treatment of CML in adults, updated version 2011
2011 |
Faculty of Medicine in Hradec Králové
publication
Bone marrow/peripheral blood positivity of Bcl-2/IgH rearrangement in patients with follicular lymphoma before treatment has no prognostic significance
2007 |
Publication without faculty affiliation
publication
Bone marrow/peripheral blood positivity of Bcl-2/IgH rearrangement in patients with follicular lymphoma before treatment has no prognostic significance
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry
2015 |
First Faculty of Medicine
publication
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer
2022 |
Second Faculty of Medicine
publication
Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma
2016 |
First Faculty of Medicine
publication
Bevacizumab with chemotherapy in patients with KRAS wild-type metastatic colorectal cancer: Czech registry data
2015 |
Publication without faculty affiliation
publication
Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer
2008 |
Third Faculty of Medicine
publication
Discontinuation of biological therapy with tyrosine kinase inhibitors in chronic myeloid leukemia patients
2014 |
Faculty of Medicine in Pilsen
publication
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy
2016 |
First Faculty of Medicine
publication
Trametinib
2016 |
First Faculty of Medicine
publication
Panitumumab as first-line treatment of colorectal cancer
2019 |
Publication without faculty affiliation
publication
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study
2023 |
Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
publication
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma
2011 |
Third Faculty of Medicine
publication
PRIMARY TESTICULAR LYMPHOMA: A CLINICOPATHOLOGIC MULTICENTRIC STUDY AND DATA FROM REGISTRY OF THE CZECH LYMPHOMA STUDY GROUP (CLSG)
2007 |
Second Faculty of Medicine
publication
Immunotherapy of Renal Cell Carcinoma
2017 |
First Faculty of Medicine
publication
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial
2012 |
Second Faculty of Medicine
publication
Panitumumab in the treatment of colorectal carcinoma
2020 |
Publication without faculty affiliation
publication
Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone
2022 |
First Faculty of Medicine
publication
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
2023 |
Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine
publication
Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer
2023 |
Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Central Library of Charles University
publication
Long-term outcome of Simpson IV meningioma resection: Would it improve with adjuvant SRS?
2021 |
First Faculty of Medicine
publication
Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL
2014 |
Third Faculty of Medicine
publication
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies
2022 |
First Faculty of Medicine
publication
Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
2015 |
Faculty of Medicine in Hradec Králové
publication
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)
2023 |
Faculty of Medicine in Pilsen, First Faculty of Medicine
publication
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma
2017 |
Faculty of Medicine in Pilsen